BriaCell Therapeutics Corp. (BCTXL) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$28.17M | -16.8% |
| 2024 | -$24.13M | -1.6% |
| 2023 | -$23.74M | -90.2% |
| 2022 | -$12.48M | -61.1% |
| 2021 | -$7.75M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$28.17M | -16.8% |
| 2024 | -$24.13M | -1.6% |
| 2023 | -$23.74M | -90.2% |
| 2022 | -$12.48M | -61.1% |
| 2021 | -$7.75M | — |